BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 9819792)

  • 1. Homing behaviour of the malignant cell clone in multiple myeloma.
    Van Riet I; Vanderkerken K; de Greef C; Van Camp B
    Med Oncol; 1998 Sep; 15(3):154-64. PubMed ID: 9819792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homing mechanisms in the biology of multiple myeloma.
    Van Camp B; Van Riet I
    Verh K Acad Geneeskd Belg; 1998; 60(3):163-94. PubMed ID: 9803879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homing mechanisms of myeloma cells.
    Van Riet I
    Pathol Biol (Paris); 1999 Feb; 47(2):98-108. PubMed ID: 10192876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homing mechanisms in the etiopathogenesis of multiple myeloma.
    Van Riet I; Bakkus M; De Greef C; Faid L; Van Camp B
    Stem Cells; 1995 Aug; 13 Suppl 2():22-7. PubMed ID: 8520507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extravasation and homing mechanisms in multiple myeloma.
    Vande Broek I; Vanderkerken K; Van Camp B; Van Riet I
    Clin Exp Metastasis; 2008; 25(4):325-34. PubMed ID: 17952614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of adhesion molecules in multiple myeloma.
    Cook G; Dumbar M; Franklin IM
    Acta Haematol; 1997; 97(1-2):81-9. PubMed ID: 8980613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homing of the myeloma cell clone.
    Vanderkerken K; Van Camp B; De Greef C; Vande Broek I; Asosingh K; Van Riet I
    Acta Oncol; 2000; 39(7):771-6. PubMed ID: 11145431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The involvement of adhesion molecules in the biology of multiple myeloma.
    Van Riet I; Van Camp B
    Leuk Lymphoma; 1993 Apr; 9(6):441-52. PubMed ID: 8339050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Migration, adhesion and differentiation of malignant plasma cells in the 5T murine model of myeloma.
    Asosingh K
    Verh K Acad Geneeskd Belg; 2003; 65(2):127-34. PubMed ID: 12870183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Marrow Microenvironment in the Growth and Development of Malignant Plasma Cells in Multiple Myeloma.
    Giannakoulas N; Ntanasis-Stathopoulos I; Terpos E
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33923357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokine receptor CCR2 is expressed by human multiple myeloma cells and mediates migration to bone marrow stromal cell-produced monocyte chemotactic proteins MCP-1, -2 and -3.
    Vande Broek I; Asosingh K; Vanderkerken K; Straetmans N; Van Camp B; Van Riet I
    Br J Cancer; 2003 Mar; 88(6):855-62. PubMed ID: 12644822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential maturation stages of monoclonal B lineage cells from blood, spleen, lymph node, and bone marrow from a terminal myeloma patient.
    Jensen GS; Mant MJ; Pilarski LM
    Am J Hematol; 1992 Nov; 41(3):199-208. PubMed ID: 1384318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow microenvironment and the progression of multiple myeloma.
    Caligaris-Cappio F; Gregoretti MG; Merico F; Gottardi D; Ghia P; Parvis G; Bergui L
    Leuk Lymphoma; 1992 Sep; 8(1-2):15-22. PubMed ID: 1493467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adhesive interactions between tumour cells and bone marrow stromal elements in human multiple myeloma.
    Faid L; Van Riet I; De Waele M; Facon T; Schots R; Lacor P; Van Camp B
    Eur J Haematol; 1996 Nov; 57(5):349-58. PubMed ID: 9003475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of multiple beta 1 integrins on circulating monoclonal B cells in patients with multiple myeloma.
    Jensen GS; Belch AR; Mant MJ; Ruether BA; Yacyshyn BR; Pilarski LM
    Am J Hematol; 1993 May; 43(1):29-36. PubMed ID: 7686332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for the existence of circulating monoclonal B-lymphocytes in multiple myeloma patients.
    Cassel A; Leibovitz N; Hornstein L; Quitt M; Aghai E
    Exp Hematol; 1990 Dec; 18(11):1171-3. PubMed ID: 2226677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of prolactin immunoreactivity in the bone marrow of untreated multiple myeloma patients.
    Gadó K; Nagy G; Hasitz A; Tóth BE; Rimanóczi E; Domján G
    Neuroimmunomodulation; 2001; 9(2):95-102. PubMed ID: 11549891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-cadherin-mediated interaction with multiple myeloma cells inhibits osteoblast differentiation.
    Groen RW; de Rooij MF; Kocemba KA; Reijmers RM; de Haan-Kramer A; Overdijk MB; Aalders L; Rozemuller H; Martens AC; Bergsagel PL; Kersten MJ; Pals ST; Spaargaren M
    Haematologica; 2011 Nov; 96(11):1653-61. PubMed ID: 21828122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restricted expression of immunoglobulin light chain mRNA and of the adhesion molecule CD11b on circulating monoclonal B lineage cells in peripheral blood of myeloma patients.
    Jensen GS; Belch AR; Kherani F; Mant MJ; Ruether BA; Pilarski LM
    Scand J Immunol; 1992 Dec; 36(6):843-53. PubMed ID: 1281335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro growth of human multiple myeloma: implications for biology and therapy.
    Caligaris-Cappio F; Gregoretti MG; Ghia P; Bergui L
    Hematol Oncol Clin North Am; 1992 Apr; 6(2):257-71. PubMed ID: 1582973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.